These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29912651)

  • 1. Fixed drug eruption due To 2,3-dimercapto-1-propanesulfonic acid (DMPS) treatment for mercury poisoning: a rare adverse effect.
    Erden F; Agis ER; Gunduzoz M; Yilmaz OH
    Acta Clin Belg; 2019 Jun; 74(3):200-202. PubMed ID: 29912651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chelation therapy in intoxications with mercury, lead and copper.
    Cao Y; Skaug MA; Andersen O; Aaseth J
    J Trace Elem Med Biol; 2015; 31():188-92. PubMed ID: 24894443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) on tissue and urine mercury levels following prolonged methylmercury exposure in rats.
    Pingree SD; Simmonds PL; Woods JS
    Toxicol Sci; 2001 Jun; 61(2):224-33. PubMed ID: 11353131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stevens-Johnson syndrome in a child with chronic mercury exposure and 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy.
    Van der Linde AA; Pillen S; Gerrits GP; Bouwes Bavinck JN
    Clin Toxicol (Phila); 2008 Jun; 46(5):479-81. PubMed ID: 18568806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of urinary mercury excretion after administration of 2,3-dimercapto-1-propane sulfonic acid to occupationally exposed men.
    Torres-Alanís O; Garza-Ocañas L; Pineyro-Lopez A
    J Toxicol Clin Toxicol; 1995; 33(6):717-20. PubMed ID: 8523500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mercury kinetics in a case of severe mercuric chloride poisoning treated with dimercapto-1-propane sulphonate (DMPS).
    Toet AE; van Dijk A; Savelkoul TJ; Meulenbelt J
    Hum Exp Toxicol; 1994 Jan; 13(1):11-6. PubMed ID: 8198824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inorganic mercury poisoning associated with skin-lightening cosmetic products.
    Chan TY
    Clin Toxicol (Phila); 2011 Dec; 49(10):886-91. PubMed ID: 22070559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and treatment of an alleged mercury and lead exposure with DMPS].
    Hakimi R
    Versicherungsmedizin; 2014 Dec; 66(4):210-2. PubMed ID: 25558512
    [No Abstract]   [Full Text] [Related]  

  • 9. Mobilization of mercury by DMPS in occupationally exposed workers and in model experiments on rats: evaluation of body burden.
    Nerudová J; Cábelková Z; Frantík E; Lukás E; Urban P; Bláha K; Pelclová D; Lebedová J; Cikrt M
    Int J Occup Med Environ Health; 2000; 13(2):131-46. PubMed ID: 10967843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Mt. Diwata study on the Philippines 2000-treatment of mercury intoxicated inhabitants of a gold mining area with DMPS (2,3-dimercapto-1-propane-sulfonic acid, Dimaval).
    Böse-O'Reilly S; Drasch G; Beinhoff C; Maydl S; Vosko MR; Roider G; Dzaja D
    Sci Total Environ; 2003 May; 307(1-3):71-82. PubMed ID: 12711426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mercury binding to the chelation therapy agents DMSA and DMPS and the rational design of custom chelators for mercury.
    George GN; Prince RC; Gailer J; Buttigieg GA; Denton MB; Harris HH; Pickering IJ
    Chem Res Toxicol; 2004 Aug; 17(8):999-1006. PubMed ID: 15310232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DMPS can reverse the features of severe mercury vapor-induced neurological damage.
    Bradberry SM; Sheehan TM; Barraclough CR; Vale JA
    Clin Toxicol (Phila); 2009 Nov; 47(9):894-8. PubMed ID: 19852623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative evaluation of urinary porphyrins as a measure of kidney mercury content and mercury body burden during prolonged methylmercury exposure in rats.
    Pingree SD; Simmonds PL; Rummel KT; Woods JS
    Toxicol Sci; 2001 Jun; 61(2):234-40. PubMed ID: 11353132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute mercury vapor poisoning in a 3-month-old infant: A case report.
    Gao Z; Ying X; Yan J; Wang J; Cai S; Yan C
    Clin Chim Acta; 2017 Feb; 465():119-122. PubMed ID: 28027882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of chelation in the treatment of arsenic and mercury poisoning.
    Kosnett MJ
    J Med Toxicol; 2013 Dec; 9(4):347-54. PubMed ID: 24178900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy and safety of chelation treatment with typical penicillamine in cross combination with DMPS repeatedly for Wilson's disease.
    Xu SQ; Li XF; Zhu HY; Liu Y; Fang F; Chen L
    J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):743-747. PubMed ID: 24142730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous injection of metallic mercury: case report and course of mercury during chelation therapy with DMPS.
    Vallant B; Deutsch J; Muntean M; Goessler W
    Clin Toxicol (Phila); 2008 Jul; 46(6):566-9. PubMed ID: 18584372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase of renal excretion of organo-mercury compounds like methlymercury by DMPS (2,3-Dimercapto-1-propanesulfonic acid, Dimaval).
    Drasch G; Boese-O'Reilly S; Illig S
    Clin Toxicol (Phila); 2007; 45(3):266-9. PubMed ID: 17453878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) on methylmercury-induced locomotor deficits and cerebellar toxicity in mice.
    Carvalho MC; Franco JL; Ghizoni H; Kobus K; Nazari EM; Rocha JB; Nogueira CW; Dafre AL; Müller YM; Farina M
    Toxicology; 2007 Oct; 239(3):195-203. PubMed ID: 17703864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mercury elimination with oral DMPS, DMSA, vitamin C, and glutathione: an observational clinical review.
    Muran PJ
    Altern Ther Health Med; 2006; 12(3):70-5. PubMed ID: 16708769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.